|
1
|
Niibe Y, Kuranami M, Matsunaga K, Takaya
M, Kakita S, Hara T, Sekiguchi K, Watanabe M and Hayakawa K: Value
of high-dose radiation therapy for isolated osseous metastasis in
breast cancer in terms of oligo-recurrence. Anticancer Res.
28:3929–3931. 2008.PubMed/NCBI
|
|
2
|
Milano MT, Zhang H, Metcalfe SK, Muhs AG
and Okunieff P: Oligometastatic breast cancer treated with
curative-intent stereotactic body radiation therapy. Breast Cancer
Res Treat. 115:601–608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Niibe Y and Hayakawa K: Oligometastases
and oligo-recurrence: The new era of cancer therapy. Jpn J Clin
Oncol. 40:107–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ogawa Y: Paradigm shift in radiation
biology/radiation oncology-exploitation of the
“H2O2 effect” for radiotherapy using low-LET
(linear energy transfer) radiation such as x-rays and high-energy
electrons. Cancers (Basel). 8:E282016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ogawa Y, Kubota K, Ue H, Kataoka Y,
Tadokoro M, Miyatake K, Tsuzuki K, Yamanishi T, Itoh S, Hitomi J,
et al: Phase I study of a new radiosensitizer containing hydrogen
peroxide and sodium hyaluronate for topical tumor injection: A new
enzyme-targeting radiosensitization treatment, Kochi
Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II
(KORTUC II). Int J Oncol. 34:609–618. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ogawa Y, Kubota K, Ue H, Tadokoro M,
Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H,
et al: Safety and effectiveness of a new enzyme-targeting
radiosensitization treatment (KORTC II) for intratumoral injection
for low-LET radioresistant tumors. Int J Oncol. 39:553–560.
2011.PubMed/NCBI
|
|
7
|
Aoyama N, Ogawa Y, Kubota K, Ohgi K,
Kataoka Y, Miyatake K, Tadokoro M, Yamanishi T, Ohnishi T, Hamada
N, et al: Therapeutic response to a new enzyme-targeting
radiosensitization treatment (KORTUC-SC) for patients with
chemotherapy-resistant supraclavicular lymph node metastasis. J
Cancer Res Ther. 1:215–219. 2013. View Article : Google Scholar
|
|
8
|
Tokuhiro S, Ogawa Y, Tsuzuki K, Akima R,
Ue H, Kariya S and Nishioka A: Development of a novel
enzyme-targeting radiosensitizer (KORTUC) containing hydrogen
peroxide for intratumoral injection for patients with low linear
energy transfer-radioresistant neoplasms. Oncol Lett. 1:1025–1028.
2010.PubMed/NCBI
|
|
9
|
Jette DC, Wiebe LI and Chapman JD:
Synthesis and in vivo studies of the radiosensitizer
4-[82Br]bromomisonidazole. Int J Nucl Med Biol.
10:205–210. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Coleman CN: Hypoxic cell radiosensitizers:
Expectations and progress in drug development. Int J Radiat Oncol
Biol Phys. 11:323–329. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lawrence TS, Blackstock AW and McGinn C:
The mechanism of action of radiosensitization of conventional
chemotherapeutic agents. Semin Radiat Oncol. 13:13–21. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Böhm L, Roos WP and Serafin AM: Inhibition
of DNA repair by pentoxifylline and related methylxanthine
derivatives. Toxicology. 193:153–160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Milas L: Cyclooxygenase-2 (COX-2) enzyme
inhibitors as potential enhancers of tumor radioresponse. Semin
Radiat Oncol. 11:290–299. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choy H and Milas L: Enhancing radiotherapy
with cyclooxygenase-2 enzyme inhibitors: A rational advance. J Natl
Cancer Inst. 95:1440–1452. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Overgaard J: Clinical evaluation of
nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol Res.
6:509–518. 1994.PubMed/NCBI
|
|
16
|
Gerlach NL, Barkhuysen R, Kaanders JH,
Janssens GO, Sterk W and Merkx MA: The effect of hyperbaric oxygen
therapy on quality of life in oral and oropharyngeal cancer
patients treated with radiotherapy. Int J Oral Maxillofac Surg.
37:255–259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Overgaard J: Hypoxic radiosensitization:
Adored and ignored. J Clin Oncol. 25:4066–4074. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Williamson RA: An experimental study of
the use of hyperbaric oxygen to reduce the side effects of
radiation treatment for malignant disease. Int J Oral Maxillofac
Surg. 36:533–540. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oronsky BT, Knox SJ and Scicinski J: Six
degrees of separation: The oxygen effect in the development of
radiosensitizers. Transl Oncol. 4:189–198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wardman P: Chemical radiosensitizers for
use in radiotherapy. Clin Oncol (R Coll Radiol). 19:397–417. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishino M, Jackman DM, Hatabu H, Yeap BY,
Cioffredi LA, Yap JT, Jänne PA, Johnson BE and Van den Abbeele AD:
New Response Evaluation Criteria in Solid Tumors (RECIST)
guidelines for advanced non-small cell lung cancer: comparison with
original RECIST and impact on assessment of tumor response to
targeted therapy. AJR Am J Roentgenol. 195:221–228. 2010.
View Article : Google Scholar
|
|
22
|
Bennett AV, Dueck AC, Mitchell SA, Mendoza
TR, Reeve BB, Atkinson TM, Castro KM, Denicoff A, Rogak LJ, Harness
JK, et al: National Cancer Institute PRO-CTCAE Study Group: Mode
equivalence and acceptability of tablet computer-, interactive
voice response system-, and paper-based administration of the U.S.
National Cancer Institute's Patient-Reported Outcomes version of
the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Health Qual Life Outcomes. 14:242016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oldenborg S, Van Os RM, Van Rij CM, Crezee
J, Van de Kamer JB, Rutgers EJ, Geijsen ED, Zum Vörde sive vörding
PJ, Koning CC and Van tienhoven G: Elective re-irradiation and
hyperthermia following resection of persistent locoregional
recurrent breast cancer: A retrospective study. Int J Hyperthermia.
26:136–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ben-Yosef R, Vigler N, Inbar M and Vexler
A: Hyperthermia combined with radiation therapy in the treatment of
local recurrent breast cancer. Isr Med Assoc J. 6:392–395.
2004.PubMed/NCBI
|
|
25
|
Zagar TM, Oleson JR, Vujaskovic Z,
Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR and Jones
EL: Hyperthermia combined with radiation therapy for superficial
breast cancer and chest wall recurrence: A review of the randomised
data. Int J Hyperthermia. 26:612–617. 2010. View Article : Google Scholar : PubMed/NCBI
|
